Skip to content

Haemonetics HAE Amortization of fair value inventory step-up

Amortization of fair value inventory step-up at other companies

Agilysys logo
AgilysysAGYS
$167K+4.4%
Bausch + Lomb logo
Bausch + LombBLCO
$0-100%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$3M-86.4%
MH
McGraw Hill, Inc.MH
$0
Steven Madden logo
Steven MaddenSHOO
$7.67M+5,435%
Clearwater Analytics logo
Clearwater AnalyticsCWAN
$3.12M+131%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept hae:AmortizationOfFairValueInventoryStepUp.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's amortization of fair value inventory step-up.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's amortization of fair value inventory step-up?
Haemonetics (HAE) reported amortization of fair value inventory step-up of $0 in Q1 2026.
How has Haemonetics's amortization of fair value inventory step-up changed year-over-year?
Haemonetics's amortization of fair value inventory step-up decreased by 100.0% year-over-year, from $2.64M to $0.
What does amortization of fair value inventory step-up mean?
This represents the non-cash expense recognized when acquired inventory is revalued to fair value at the time of a business combination. It reflects the incremental cost of goods sold as this inventory is subsequently sold to customers. Investors track this to understand the impact of purchase accounting adjustments on reported profitability.